Labcorp Cash Flow from Operating Activities 2010-2024 | LH
Labcorp annual/quarterly cash flow from operating activities history and growth rate from 2010 to 2024. Cash flow from operating activities can be defined as a company's cash flows from operations.
- Labcorp cash flow from operating activities for the quarter ending March 31, 2024 was $-0.030B, a 124.59% decline year-over-year.
- Labcorp cash flow from operating activities for the twelve months ending March 31, 2024 was $2.519B, a 41.54% decline year-over-year.
- Labcorp annual cash flow from operating activities for 2023 was $1.328B, a 32.12% decline from 2022.
- Labcorp annual cash flow from operating activities for 2022 was $1.956B, a 37.1% decline from 2021.
- Labcorp annual cash flow from operating activities for 2021 was $3.11B, a 45.63% increase from 2020.
Labcorp Annual Cash Flow Ops
(Millions of US $) |
| 2023 |
$1,328 |
| 2022 |
$1,956 |
| 2021 |
$3,110 |
| 2020 |
$2,135 |
| 2019 |
$1,445 |
| 2018 |
$1,305 |
| 2017 |
$1,498 |
| 2016 |
$1,197 |
| 2015 |
$982 |
| 2014 |
$739 |
| 2013 |
$819 |
| 2012 |
$841 |
| 2011 |
$856 |
| 2010 |
$884 |
| 2009 |
$862 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$16.431B |
$12.162B |
|
Laboratory Corporation of America Holdings or LabCorp is a leading healthcare diagnostics company, providing comprehensive clinical laboratory services and end-to-end drug development support. The provide vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.
|
